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Zebrafish fully regenerate lost bone, including after
fin amputation, through a processmediated by dedif-
ferentiated, lineage-restricted osteoblasts. Mecha-
nisms controlling the osteoblast regenerative
program from its initiation through reossification
are poorly understood. We show that fin amputation
induces a Wnt/b-catenin-dependent epithelial to
mesenchymal transformation (EMT) of osteoblasts
in order to generate proliferative Runx2+ preosteo-
blasts. Localized Wnt/b-catenin signaling maintains
this progenitor population toward the distal tip of
the regenerative blastema. As they become proxi-
mally displaced, preosteoblasts upregulate sp7 and
subsequently mature into re-epithelialized Runx2/
sp7+ osteoblasts that extend preexisting bone. Auto-
crine bone morphogenetic protein (BMP) signaling
promotes osteoblast differentiation by activating
sp7 expression and counters Wnt by inducing Dick-
kopf-related Wnt antagonists. As such, opposing
activities of Wnt and BMP coordinate the simulta-
neous demand for growth and differentiation during
bone regeneration. This hierarchical signaling net-
work model provides a conceptual framework for
understanding innate bone repair and regeneration
mechanisms and rationally designing regenerative
therapeutics.INTRODUCTION
Among mammalian organs, bones have unusually effective
repair mechanisms, as demonstrated by continuous bone
remodeling throughout life and the scarless healing of some
fractures. Still, traumatic injuries or disease frequently exceed
the innate regenerative capacities of human bone (Dimitriou
et al., 2011). Envisioned restorative bone therapies include,
for example, engineered cell scaffolds combined with bone
grafts and the delivery of manipulated stem cells including
patient-specific induced pluripotent stem cells. An appealing
alternative is to recapitulate mechanisms observed in animals482 Cell Reports 6, 482–498, February 13, 2014 ª2014 The Authorswith remarkable capacities for self-repair, including fish and
salamanders.
Osteoblasts are specialized bone producing cells that deposit
a unique extracellular matrix, the osteoid, that mineralizes to
form mature bone. Two transcription factors, Runx2 and sp7/
Osterix (Osx), are key determinants of the osteoblast lineage
(Long, 2012). Runx2-null mice lack all ossification (Ducy et al.,
1997; Komori et al., 1997; Otto et al., 1997). Similarly, Sp7-defi-
cient mice do not form bone due to a failure of osteoblasts to
differentiate (Nakashima et al., 2002). Runx2 functions upstream
of Sp7; Runx2-deficient mice fail to express Sp7, whereas Sp7-
null mice retainRunx2 expression (Nakashima et al., 2002). Tran-
scriptional control of Runx2 and Sp7 is mediated via cell
signaling including by the Wnt and bone morphogenetic protein
(BMP) pathways, both central components of bone develop-
mental regulatory networks (Long, 2012).
Wnts are secreted proteins that function in many biological
processes, including development and cancer (Clevers and
Nusse, 2012). Wnts bind to Frizzled (Fz) and Lrp5/6 coreceptors
culminating in the stabilization and nuclear translocation of
b-catenin. Nuclear b-catenin functions with Tcf/Lef transcription
factors to affect gene expression (Clevers and Nusse, 2012).
Given Wnt’s signaling potency in influencing cell behavior and
lineage decisions, the pathway is under tight control (Clevers
and Nusse, 2012). For instance, the Dickkopf family of secreted
Wnt antagonists moderate Wnt activity by binding to and block-
ing Lrp5/6 (Mao et al., 2001). Deletion of mouse b-catenin in early
mesenchymal precursors results in loss of Runx2 and Sp7
expression and a corresponding failure of bone formation, sug-
gesting osteogenesis requires Wnt/b-catenin signaling (Day
et al., 2005; Glass et al., 2005; Gong et al., 2001; Hill et al.,
2005; Hu et al., 2005; Rodda and McMahon, 2006).
The BMP pathway is an additional key regulator of osteogene-
sis. Secreted BMPs bind and activate specific BMP serine/threo-
nine kinase receptors (BMPRs). BMPRs phosphorylate Smad1/
5/8 transcription factors, inducing their translocation to the nu-
cleuswhere they activate downstreamgenes. BMPs are required
for osteoblast-lineage commitment of cranialmesenchyme (Abz-
hanov et al., 2007), and loss of both Bmp2 and Bmp4 results in a
severe defect in osteoblast differentiation likely due to a failure
of Runx2-expressing cells to upregulate Sp7 (Bandyopadhyay
et al., 2006). These and earlier studies led to the development
of recombinant BMPs as therapies to augment bone healing,
albeit with debated clinical benefits (Garrison et al., 2010).
Mammalian bone fracture repair is mediated by bone-marrow-
derived mesenchymal stem cells that differentiate into osteo-
blasts and subsequently produce remineralized bone (Dimitriou
et al., 2011). Several signaling pathways, including Wnt and
BMP, have been implicated in these repair processes, but their
modes of action at the cellular and molecular level are largely
unknown. Forexample, it is unclearwhetherWntsandBMPs influ-
ence discrete osteoprogenitor populations or how expression of
Runx2 andSp7 themaster regulators of osteogenesis, are coordi-
nated during the repair process (Dimitriou et al., 2011). Evenmore
confoundingareobservations that,whereasbothWnts andBMPs
positively influence bone repair, the pathways appear to function
in opposition to one another (Minear et al., 2010a).
Adult zebrafish fins comprise multiple organized cell types,
including osteoblasts, fibroblasts, endothelial cells, neurons,
and epidermal cells. Each of these cell types regenerate in con-
cert after resection to perfectly restore the entire fin within
2–3 weeks (Gemberling et al., 2013). The bony rays, or lepidotri-
chia, that characterize fish fins are ossified spokes lined with
bone forming osteoblasts. Lineage-tracing studies demonstrate
that replacement osteoblasts are derived from preexisting uni-
potent osteoblasts (Knopf et al., 2011; Singh et al., 2012; Sousa
et al., 2011; Stewart and Stankunas, 2012; Tu and Johnson,
2011), although an unknown population can substitute if needed
(Singh et al., 2012). These observations indicate that mature
osteoblasts respond to injury by acquiring progenitor cell
properties, a process known as dedifferentiation. These fate
restricted cells then populate lateral regions of the regenerative
blastema, specialized mesenchymal tissue formed upon ampu-
tation. Subsequently, by poorly understood mechanisms, the
osteoblast lineage cells undergo coordinated proliferation, dif-
ferentiation, and morphogenesis to form replacement bone.
Fin regeneration is accompanied by upregulation of tran-
scripts associated with osteogenesis including runx2a, runx2b,
and sp7 (Knopf et al., 2011; Smith et al., 2006; Sousa et al.,
2011). Transgenic lines utilizing fish sp7 promoter/enhancer ele-
ments indicate that fin osteoblasts distal to the amputation site
express sp7, whereas cells below the amputation site downre-
gulate sp7 expression (DeLaurier et al., 2010; Knopf et al.,
2011; Singh et al., 2012). Similarly, human Runx2 regulatory ele-
ments drive reporter gene expression in cells distal to the ampu-
tation site (Knopf et al., 2011). Although the Wnt/b-catenin
pathway is required for fin regeneration and components of the
Wnt pathway are expressed in the regenerating fin (Kawakami
et al., 2006; Poss et al., 2000; Stoick-Cooper et al., 2007), it re-
mains unknown which cell types participate in Wnt/b-catenin
signaling or how the pathway promotes regeneration. Similarly,
BMP gene expression patterns and overexpression of the BMP
inhibitor Chordin implicate the BMPpathway in fin osteoblast dif-
ferentiation (Smith et al., 2006). However, it is unresolved how
BMP promotes bone differentiation or even when and where
BMP signaling is active during regeneration.
Here, we examine mechanisms of regenerative osteogenesis
in the zebrafish caudal fin. Upon fin amputation, Runx2+ preos-
teoblasts accumulate in the blastema following a Wnt/b-catenin
dependent epithelial-to-mesenchymal transformation (EMT) of
osteoblasts lining the damaged bone. Distal Wnt signaling
continuously maintains Runx2+ preosteoblasts, whereas theirCdifferentiation into mature, sp7+ osteoblasts is promoted by
autocrine BMP signaling. By inducing secretedWnt antagonists,
including dkk1b, BMP facilitates negative crosstalk between
differentiating osteoblasts and preosteoblasts. This straightfor-
ward signaling network produces a hierarchically and spatially
organized osteoblast lineage that balances a simultaneous
need for bone growth and differentiation until fin regeneration
is complete.
RESULTS
Runx2 and sp7 Define a Hierarchical Organization of
Osteoblast Lineage Cells during Fin Regeneration
We immunostained paraffin-sectioned fins with antibodies
directed against the osteogenic transcription factors, Runx2
and sp7, at various times postamputation. At 24 hr postamputa-
tion (hpa), osteoblasts lining preexisting bone adjacent to the
amputation site upregulated expression of Runx2. Further,
Runx2, but not sp7, expressing cells were found distal to the
amputation site distributed in the mesenchymal tissue of the
forming blastema (Figures 1A–1C). At 32 hpa, sp7 expression
was induced in select Runx2+ mesenchymal cells (Figures 1D–
1F). By 48 hpa, osteoprogenitors became more linearly orga-
nized adjacent to the basal epidermis with Runx2/sp7+ cells
first becoming detected near the amputation site (Figures 1G–
1I). At 72 hpa, the osteoblast lineage was highly organized along
the proximal-distal axis (Figures 1J–1L). Runx2+ cells were
always the most distally localized population and were neigh-
bored by Runx2+/sp7+ cells. In contrast, sp7+ cells were concen-
trated near the amputation site. Similarly, runx2a and sp7
transcripts were enriched at the distal and proximal ends of
the blastema, respectively (Figures 1M and 1N).
We quantified osteoblast subtypes and their proliferation state
by delivering 5-ethynyl deoxyuridine (EdU) to label cells in
S phase 6 hr prior to harvesting fins at 72 hpa. In stained section
fins, we observed robust EdU labeling in the distal blastema
mesenchyme but only rarely in the epidermis (Figures 1O and
1P), in agreement with a previous report (Smith et al., 2006).
Runx2+ and Runx2+/sp7+ cells were found in equal proportion
(Figures 1O, 1P, and 1Q, 45%) with significantly fewer sp7+
cells (Figure 1Q, 8%, p < 105). More Runx2+ cells incorpo-
rated EdU compared to sp7+ cells (16% versus 7%) (Figure 1Q,
p < 0.03). We also routinely saw clusters of several high-express-
ing Runx2+ cells that were EdU, suggesting there are distinct
proliferative and nonproliferative Runx2+ preosteoblasts (Fig-
ure 1P, red arrows). The temporal and spatial patterns of
Runx2 and sp7 expression and osteoblast-subtype proliferation
demonstrate a hierarchical organization of the osteoblast lineage
in regenerating fins. Renewing Runx2+ preosteoblasts at the
leading edge of the fin beget proliferative Runx2+/sp7+-differen-
tiating cells. These cells subsequently mature into relatively
quiescent sp7+ osteoblasts that append to progressively elon-
gating bone.
A twist2-Associated Epithelial-to-Mesenchymal
Transition Generates Preosteoblasts
We performed lineage tracing to confirm the distal, leading
edge Runx2+ cells were derived from preexisting osteoblasts.ell Reports 6, 482–498, February 13, 2014 ª2014 The Authors 483
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Figure 1. Runx2 and sp7 Define Distinct
Populations of Preosteoblasts in Regener-
ating Fins
(A–L)Runx2 (red)andsp7 (green) immunostainingat
24 (A–C), 32 (D–F), 48 (G–I), and 72 (J–L) hr post-
amputation (hpa) on longitudinal caudal fin sec-
tions. Images are maximum intensity projections of
confocal z-stacks. Amputation planes are indicated
with a dashed yellow line, white arrows point to
Runx2+ cells proximal to the amputation site, red
arrows indicate Runx2+ cells distal to the amputa-
tion site, yellow arrows denote Runx2+/sp7+cells,
and green arrows show sp7+ cells. For (I) and (L),
regions bound by dashedwhite boxes are shown in
higher magnification in inset panels.
(M and N) RNA in situ hybridizations showing
runx2a and sp7 expression on fin sections har-
vested 72 hpa. Red and green arrows point to
lateral blastema cells expressing runx2a and sp7,
respectively.
(O and P) Immunostaining showing Runx2 (red)
and sp7 (green) expression (O) and incorporation
of EdU (P, white, 6 hr pulse) on 72 hpa fin sections.
The white arrow points to an extreme distally
located EdU+ blastema cell. The yellow and green
arrows indicate Runx2+/EdU+ and sp7+/EdU
cells, respectively. Red arrows show high Runx2+/
EdU cells. In all overlay images, Hoechst-stained
nuclei are shown in blue. The scale bars repre-
sent 50 mm.
(Q) Quantitation of osteoblast subtypes and EdU
incorporation at 72 hpa. Bars show the mean
percentile representation of osteoblast subtypes
on comparable sections (n = 12 rays, compiled
from >4 fish). Error bars are one SD from themean,
and significant p values are indicated with an
asterisk (p < 105, Student’s t tests comparing
either Runx2+ or Runx2+/sp7+ populations to sp7+
cells). The proportion of each cell population that
incorporated EdU is indicated by the extent of
gray shading relative to the bar’s height. Fewer
sp7+ relative to Runx2+ cells incorporated EdU
(p < 0.03, one-tailed Fisher’s exact test, n = 547
Runx2+ and 75 sp7+ cells).We generated adult zebrafish with caudal fins containing
isolated fin rays lined with permanently labeled mCherry+
osteoblasts (Stewart and Stankunas, 2012) (Figure 2A). At484 Cell Reports 6, 482–498, February 13, 2014 ª2014 The Authors72 hpa, fins from the same animal dis-
played abundant mCherry+ osteoblasts
in the regenerating tissue (Figure 2B).
Immunostaining showed that Runx2+
cells extending from labeled hemirays
coexpressed mCherry (Figures 2C–2H).
Likewise, Runx2+ blastema cells ob-
served at 24 or 48 hpa were also derived
from mosaic-labeled osteoblasts (Fig-
ure S1). These results demonstrate
that fin amputation triggers the migra-
tion of osteoblasts closely associated
with the bone ray into the nascent
blastema following their upregulation ofRunx2. These Runx2+ blastema cells are the precursors to
redifferentiated osteoblasts that will line and mineralize replace-
ment bone.
We hypothesized that fin amputation induces an epithelial-
to-mesenchymal transformation (EMT) of osteoblasts, which
display an underappreciated epithelial-like organization (Ferrari
et al., 2000; Izu et al., 2011), to generate Runx2+ preosteoblasts.
We immunostained nonregenerating fins with zns-5 (Johnson
and Weston, 1995), a-catenin, and b-catenin antibodies to label
osteoblasts (zns-5) and adherens junctions that interconnect
epithelial sheets (catenins). Zns-5-positive osteoblasts ex-
pressed both a- (Figures 2I–2L) and b-catenin (Figure S2A),
which were concentrated at membranes separating individual
osteoblasts, demonstrating that fin ray osteoblasts have epithe-
lial-like properties.
We examined a-catenin localization in 96 hpa fins from
transgenic Tg(sp7:EGFP)b1212 animals, which express EGFP
in mature and differentiating osteoblasts (DeLaurier et al.,
2010). We saw membrane-localized a-catenin staining in both
Runx2+/sp7:EGFP+ and sp7:EGFP+ cells that were in close prox-
imity to new bone. In contrast, distally located Runx2+ cells did
not express a-catenin, suggesting they lacked adherens junc-
tions (Figures 2M–2R). N-cadherin, another component of adhe-
rens junctions (Lim and Thiery, 2012), also was expressed
in maturing osteoblasts (Figures S2B–S2E). At 24 hpa, we
observed a-catenin staining only in the fin epidermis (Figures
2S and 2T), indicating that osteoblasts rapidly lose a-catenin
expression as they populate the blastema and acquire a progen-
itor state. Further indicative of EMT, osteoblasts changed cell
shape from strikingly long and thin epithelial cells lining nonre-
generating bone to a more compact, polygonal morphology
when they became Runx2+ and Runx2+/sp7+ blastema-popu-
lating cells (compare Figures S3E and S3F).
EMTs are directed by transcription factors including Snail/
Slug and Twist (Lim and Thiery, 2012). In developing bone,
Twist1 and Twist2 are expressed in Runx2+ preosteoblasts
where Twist interacts with Runx2 (Bialek et al., 2004; Fulzele
et al., 2010; Tran et al., 2010). RNA in situ hybridization showed
that both twist2 and runx2a were induced at 24 hpa in tissue
immediately adjacent to the amputation site (Figures 2U and
2V). Combining fluorescent in situ hybridization with Runx2
immunostaining on 72 hpa sections succinctly demonstrated
that distal Runx2+ cells coexpressed twist2 mRNA (Figures
2W–2Y) and are thus bona fide mesenchymal cells. Similar to
twist2, twist3 was expressed at 24 hpa adjacent to the ampu-
tated bone (Figure S2G) and by 72 hpa was distally localized
in a pattern reminiscent of twist2 (Figures S2F and S2H). We
conclude that Runx2+ cells originate from an EMT of epithe-
lial-organized differentiated osteoblasts present near the
amputation site, and, throughout regeneration, distal Runx2+
preosteoblasts are maintained in a mesenchymal twist2/3-
expressing state. However, the initial induction of Runx2 ex-
pression does not appear to depend on EMT, because epithelial
osteoblasts lining the bone proximal to the amputation site also
upregulate Runx2+ (Figure 1).
Wnt/b-Catenin Signaling Is Active in Preosteoblasts
Wnts promote EMT (Stark et al., 1994), osteogenesis (Day et al.,
2005; Hill et al., 2005; Hu et al., 2005), and fin regeneration (Poss
et al., 2000; Kawakami et al., 2006; Stoick-Cooper et al., 2007).
We monitored Wnt signaling in regenerating fins by examiningCb-catenin localization by antibody staining. At 24 and 32 hpa,
we saw Runx2+ cells with diffuse nuclear b-catenin localization
dispersed in the mesenchyme distal to the amputation site (Fig-
ures 3A–3F). Nuclear b-catenin was still apparent at 48 hpawhen
Runx2+ cells became organized along the anterior-posterior
body axis (Figures 3G–3I). At 72 hpa, strong nuclear b-catenin
staining persisted in distally residing Runx2+ preosteoblasts,
with less nuclear b-catenin in maturing osteoblasts located
closer to the amputation site (Figures 3J–3L), suggesting that
downregulation of Wnt signaling accompanies osteoblast differ-
entiation. At 96 hpa, Tg(sp7:EGFP) animals showed robust
nuclear b-catenin primarily in distal Runx2+ cells and not in
proximal osteoblasts that expressed only sp7:EGFP (Figures
3M–3R and S3A–S3D). High-magnification single optical sec-
tions confirmed overlapping nuclear b-catenin and Runx2 in
distal osteoblasts at 96 hpa (Figures 3S–3U). Expression of the
Wnt transcriptional effector tcf7 was also enriched in Runx2+
osteoblasts (Figures 3V–SX, S3G, and S3H), supporting the
potential of Runx2+ cells to respond to Wnt signals.
We examined axin2 expression, a well-accepted target gene
of canonical Wnt signaling (Clevers and Nusse, 2012), to monitor
Wnt-responsive cell types in the regenerating fin. At 72 hpa,
axin2 was strongly expressed in distal Runx2+ preosteoblasts
(Figures 3Y–3AA, S3I, and S3J). Axin2 transcripts additionally
were detected in Runx2 cells directly medial to the preosteo-
blasts and extending to the extreme tip of the blastema. These
nonosteoblasts also showed low levels of nuclear b-catenin
(Figures S3A–S3D). We further examined Wnt activity using
Tg(TOP:GFP)w25 transgenic fish that express destabilized
GFP under the control of a synthetic Wnt-responsive promoter
(Dorsky et al., 2002). Due to the rapid turnover of the destabi-
lized GFP, we monitored GFP expression by in situ hybridiza-
tion. At 72 hpa, TOP:GFP was found in cells of the distal
blastema, including Runx2+ preosteoblasts, in a pattern indis-
tinguishable from axin2 (Figures 3BB–3DD). We did not ob-
serve nuclear b-catenin, axin2 or TOP:GFP expression in the
epidermis, suggesting that Wnt/b-catenin is not a major regu-
lator of fin epidermis regeneration even though the basal
epidermis expresses the Wnt effector lef1 (Poss et al., 2000).
Collectively, the striking nuclear b-catenin, axin2 expression,
and TOP:GFP activity in leading edge Runx2+ cells suggest
ongoing roles for canonical Wnt signaling in regulating Runx2+
preosteoblasts from their earliest EMT-driven emergence
following amputation through later stages of regenerative
outgrowth. Our data further indicate that nonosteoblast lineage
cells in the distal blastema represent an additional node of Wnt/
b-catenin signaling.
Wnt Production and Signaling Is Required for
Osteoblast EMT
Wnt is one secreted factor that can initiate EMT during embry-
onic development (Lim and Thiery, 2012; Stark et al., 1994),
and Wnts induce twist expression during mouse craniofacial
bone development (Tran et al., 2010). We performed loss-of-
function studies of Wnt signaling during fin regeneration using
IWP-2, a small molecule inhibitor of Porcupine, an acyltransfer-
ase that covalently modifies Wnts and is required for their
secretion (Chen et al., 2009). We treated Tg(sp7:EGFP) animalsell Reports 6, 482–498, February 13, 2014 ª2014 The Authors 485
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with IWP-2 and monitored regeneration in individual animals
from 0 to 8 dpa. At 2 and 4 dpa, IWP-2-treated fish arrested
regeneration after forming a wound epidermis and lacked
sp7:EGFP+ osteoblasts beyond the amputation site (Figure S4).
By 8 dpa, control animals had substantially regenerated and
sp7:EGFP+ osteoblasts were seen throughout the regenerate
(Figures 4A–4D and S4). In contrast, IWP-2-treated fish dis-
played no regenerative outgrowth, although bone proximal
to the amputation site continuously maintained sp7:EGFP+
expression (Figures 4E–4H and S4). Low doses (100 nM) of
Wnt-C59, a chemically distinct Porcupine inhibitor (Proffitt
et al., 2013), also completely inhibited bone regeneration (Fig-
ures S5A–S5D).
Given the complete lack of bone regeneration in both IWP-2-
and Wnt-C59-treated fish, we speculated that an initiating
step(s) requires Wnt activity. Sections of fins from fish treated
with IWP-2 from 0 to 24 hpa lacked both nuclear-localized b-cat-
enin and Runx2-expressing blastema cells (Figures 4I–4P).
However, Runx2 expression was still evident in bone-lining oste-
oblasts near the amputation site, suggesting its initial activation
isWnt-independent (Figures 4I–4P). A later treatment with IWP-2
from 48 to 72 hpa abolished twist2 expression (Figures 4Q and
4R). These results demonstrate that Wnt initiates osteoblast
EMT and then maintains the mesenchymal state of preosteo-
blasts by promoting twist2 expression.
Wnt/b-Catenin Signaling Maintains Runx2+
Preosteoblasts
We tested if Wnt has an ongoing role maintaining preosteoblasts
during bone regrowth by blocking Wnt production from 48 to
72 hpa using IWP-2. This IWP-2 regimen stunted overall regen-
eration and depleted osteoblast-lineage cells distal to the ampu-
tation site (Figures 5A–5D). The few remaining cells displayed
membrane-localized b-catenin and reduced levels of Runx2
(Figures 5A and 5B), whereas sp7 expression was largely un-
changed (Figures 5C and 5D). Along with fewer osteoblasts,
fins from IWP-2-treated fish had a pronounced decrease in
collagen deposition near amputated bones (Figures S5M–S5P).
Although the small number of osteoblasts remaining after a
24 hr IWP-2 treatment precluded a detailed analysis, we were
able to rule out apoptosis as a cause of the phenotype by TUNEL
staining (Figures S5Q–S5V).Figure 2. Dual Epithelial/Mesenchymal Nature of Osteoblasts during F
(A–H) Whole-mount imaging of a mosaic bone ray before amputation (A) and at 72
of mCherry (magenta, indicated bymagenta arrows). Sections of the same ray at 7
shown in (E) and (H). Yellow arrows show distal mCherry+/Runx2+ cells, and the
sites are indicated with a dashed line. (F)–(H) are high-magnification images of a
(I–L) Antibody-stained transverse sections of nonregenerating fins showing a-cate
osteoblasts.
(M–R) A section from a 96 hpa Tg(sp7:EGFP) fin showing Runx2+ (white), sp7:EG
boxes in (P) are shown at higher magnification in (Q) and (R). White arrows point t
membrane-localized a-catenin.
(S and T) Expression of Runx2 (red) and a-catenin (green) on 24 hpa sections. R
(U and V) Whole-mount RNA in situ hybridizations of runx2a (U) and twist2 (V) a
regenerating tissue.
(W–Y) Runx2 immunostaining (W, red) and twist2 in situ hybridization (X, green) is s
Runx2+ preosteoblasts. Hoechst-labeled nuclei are in blue.
Scale bars represent 50 mm except in H, which represents 5 mm.
CAt least two populations of distally located cells transmit Wnt
signals in the regenerating fin: Runx2+ preosteoblasts and adja-
cent nonosteoblast distal mesenchymal cells. Therefore, the loss
of osteoblasts after 24 hr IWP-2 treatment could represent direct
and/or indirect Wnt signaling roles. To distinguish between these
possibilities, we inhibited Wnt for brief periods (8 hr) during
regeneration andmonitored b-catenin, Runx2, and sp7 by immu-
nostaining. Administration of IWP-2 or Wnt-C59 from 64 to
72 hpa was sufficient to inhibit nuclear localization of b-catenin
(Figures 5E and 5F and S5E–S5L). An examination of osteoblast
subtypes (Figures 5G–5J) indicated both IWP-2- and Wnt-C59-
treated fish contained fewer Runx2+ cells (Figure 5I, p < 0.02)
and increased numbers of Runx2+/sp7+ cells (Figure 5I, p <
0.02). However, no significant difference in the number of sp7+
cells was observed (Figure 5I). EdU incorporation in Runx2+
cells, but not sp7-expressing osteoblasts, was also reduced
in fish treated with either IWP-2 or Wnt-C59 (Figure 5J, p <
0.003), indicating that Wnt-dependent proliferation specifically
maintains Runx2+ preosteoblasts. We also quantified Runx2
and sp7 expression on sections from multiple animals and pro-
duced scatterplots depicting normalized expression levels in in-
dividual cells. Confirming our qualitative observations, there was
a 3.1-fold decrease in the fraction of Runx2 single positive cells
relative to all mesenchymal cells in animals treated with IWP-2
from 64 to 72 hpa (Figures S5W and S5X).
We developed a method to isolate and culture primary fin
osteoblasts where 78.5% of the cells stained positively for
Runx2 and/or sp7 (SD = 8.3%, n = 5 independent cell prepa-
rations). To test if Wnt directly promotes fin osteoblast pro-
liferation, we treated these cultures with Wnt3A and monitored
EdU incorporation in Runx2+ cells. Wnt3A significantly in-
creased the fraction of EdU+/Runx2+ cells (Figures S5Y–
S5DD, p = 0.0021). We conclude that, in regenerating fins,
continuously secreted Wnt activates canonical Wnt signaling
in Runx2+ preosteoblasts to support, directly or indirectly, their
renewal.
BMPSignaling Promotes sp7Expression andOsteoblast
Differentiation during Bone Regeneration
BMPs have been implicated in osteoblast differentiation (Abzha-
nov et al., 2007; Bandyopadhyay et al., 2006) and are expressed
in fin osteoblasts during regeneration (Smith et al., 2006). Wein Regeneration
hpa (B) showing osteoblasts permanently labeled by Cre-mediated expression
2 hpa immunostained for Runx2 (C and F) andmCherry (D and G). Overlays are
green arrow points to a mCherry/Runx2+ distal osteoblast (C–H). Amputation
nother section through the same ray in (C)–(E).
nin (green) and zns-5 (red). Yellow arrows indicate epithelial a-catenin+/zns-5+
FP (green), and a-catenin (red) expression. Regions bounded by dashed white
o Runx2+ preosteoblasts and green arrows show sp7:EGFP+ osteoblasts with
ed arrows indicate Runx2+/a-catenin mesenchymal cells.
t 24 hpa. Red arrows denote the specific expression of runx2a and twist2 in
hown on 72 hpa frozen sections and overlaid (Y). Yellow arrows point to twist2+/
ell Reports 6, 482–498, February 13, 2014 ª2014 The Authors 487
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Figure 3. Wnt/b-Catenin Signaling in Preosteoblasts during Regeneration
(A–L) Immunostaining of Runx2 (red) and b-catenin (green) on fin sections at 24 (A–C), 32 (D–F), 48 (G–I), and 72 (J–L) hpa. Yellow arrows indicate Runx2+ cells with
nuclear b-catenin, and the red arrows point to proximal osteoblasts at 72 hpa with membrane-localized b-catenin. For (L), regions bounded by dashed white
boxes are shown in higher magnification in inset panels.
(M–R) Expression of Runx2 (M, white), sp7:EGFP (O, green), and localization of b-catenin (N, red) is shown and overlaid (P–R) on 96 hpa Tg(sp7:EGFP) section.
Regions bound by dashed white boxes in (P) are shown at higher magnification in (Q) and (R). Yellow arrows highlight Runx2+ cells with nuclear-localized
b-catenin, and green arrows indicate membrane-localized b-catenin in sp7:EGFP+ osteoblasts.
(S–U) A single optical section at 96 hpa fin showing immunostaining of Runx2 (red) and b-catenin (green) in distal preosteoblasts. Yellow arrows point to Runx2+
nuclei containing b-catenin, and the green arrow indicates exclusively membrane-localized b-catenin in the fin epidermis.
(V–X) Runx2 immunostaining (V, red) and tcf7 in situ hybridization (W, green) on a 72 hpa cryosection (X, overlay). The yellow arrow indicates distal Runx2+
preosteoblasts that coexpress tcf7; the red arrow indicates proximal osteoblasts lacking tcf7 expression.
(Y–AA) Runx2 immunostaining (Y, red) combined with axin2 in situ hybridization (Z, green) is shown on a 72 hpa cryosection and overlaid (AA). Yellow arrows point
to distal preosteoblasts coexpressing axin2 and Runx2. The white arrow indicates distal nonosteoblast blastema cells that express axin2. The red arrow shows
proximal osteoblasts without axin2 expression.
(BB–DD) Runx2 immunostaining (BB, red) and GFP in situ hybridization (CC, green) on a 72 hpa section from a Tg(TOP:GFP) fin shown in overlay (DD). Yellow
arrows show Runx2+/GFP+ preosteoblasts. The white arrow indicates distal nonosteoblast blastema cells that express the reporter. Hoechst-stained nuclei are
shown in blue. Scale bars represent 50 mm except in U, which represents 5 mm.
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Figure 4. Wnt/b-Catenin Is Required for Osteoblast EMT and Dedifferentiation
(A–H) Regeneration of Tg(sp7:EGFP) fins after treatment with DMSO (A–D) or IWP-2 (E–H, 10 mM from 0 to 8 dpa). Rotterman contrast (A, C, E, G) and epi-
fluorescence (B, D, F, H) images show sp7:EGFP expression in osteoblasts (white arrows) before amputation (A, B, E, F) and at 8 dpa (C, D, G, H). Shown are 253
images from one of three fish for control and IWP-2 groups and regions within dashed white boxes are shown at 1203 magnification.
(legend continued on next page)
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examined the pattern of BMP activity by staining fin sections
from 96 hpa Tg(sp7:EGFP) fish with antibodies against phos-
phorylated, active Smad1, 5, and 8 (pSmad1/5/8), Runx2, and
EGFP. We observed pSmad1/5/8 in differentiating sp7:EGFP+
cells but not Runx2+/sp7:EGFP preosteoblasts or other cell
types (Figure 6A). pSmad1/5/8 staining was evident by 48 hpa,
coincident with the appearance of sp7+ maturing osteoblasts
(Figures S7A–S7D). The discrete localization of pSmad1/5/8
suggests that differentiating osteoblasts are the primary targets
of BMP signals during fin regeneration and that the pathway pro-
motes osteoblast redifferentiation.
We blocked BMP signaling in Tg(sp7:EGFP) animals using
the BMPR inhibitor (BMPRi) LDN193189 (Cuny et al., 2008)
from 0 to 8 dpa (Figures 6B–6I and S6). At 2 dpa, we could
not distinguish BMPRi-treated from control fish, but by 4 dpa
BMP inhibition produced a pronounced decrease in the extent
and levels of sp7:EGFP expression (Figure S6). Paradoxically,
by 8 dpa of BMPRi treatment, sp7:EGFP expression became
relatively high, possibly indicating the activation of feedback
mechanisms (Figure S6). Regardless, long-term inhibition of
the BMP pathway (0–8 dpa) reduced bone formation (Figures
6B–6I) with BMPRi-treated fish lacking mature lepidotrichia
including the joints between ray segments but maintaining
regeneration of epidermis and blood vessels at 4 dpa (Figures
S7E–S7H). Von Kossa staining revealed that fins from BMPRi-
treated fish still formed a blastema but failed to produce miner-
alized bone (Figures S7I–S7L), consistent with a reduced
expression domain of col10a1, a marker of differentiating oste-
oblasts (Smith et al., 2006) (Figures S7M and S7N). Importantly,
pSmad1/5/8 levels were greatly diminished by chronic BMPRi
treatment (Figures S7O and S7P), demonstrating drug efficacy.
The bone-specific phenotype induced by BMPRi exposure con-
trasts those observed with IWP-2 or Wnt-C59, which largely
blocked blastema outgrowth, and is consistent with the obser-
vation that BMP activity is primarily located in differentiating
osteoblasts.
To determine BMP roles during ongoing regeneration, we
treated animals with BMPRi from 48 to 72 hpa, which blocked
Smad1/5/8 phosphorylation, increased Runx2+ cells near the
amputation site (Figures 6J–6O), and decreased sp7 expression
(Figures 6P and 6R). We scored osteoblast subtypes in DMSO
versus BMPRi-treated animals (Figure 6T), confirming BMPRi
treatment increased Runx2+ cells (p < 0.002) and decreased
the Runx2+/sp7+ and the sp7+ populations (p < 0.007 for the
Runx2+/sp7+ cells and p < 0.02 for the sp7+ population). EdU
incorporation (Figures 6Q and 6S, quantified in Figure S7Q)
and TUNEL staining (Figures S5Q–S5V) revealed osteoblast
proliferation and cell death, respectively, were unaffected by
BMPRi treatment. These results argue against a role for BMP
in maintaining Runx2 expression (Smith et al., 2006) and rather
demonstrate that BMP specifically drives osteoblast differentia-
tion by promoting the transition from Runx2+/sp7 cells to sp7+
cells.(I–P) Immunostaining for Runx2 (red) and b-catenin (green) on 24 hpa sections fr
24 hpa). The yellow arrow indicates Runx2+ cells with nuclear-localized b-cateni
(Q and R) twist2 in situ hybridization on fins from DMSO (Q) and IWP-2-treated (R,
expressing osteoblasts.
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Regenerating Osteoblasts
Because inhibiting BMP activity expanded the Runx2+ popula-
tion, we hypothesized that BMP signaling in proximally located
osteoblasts quenches Wnt/b-catenin activity. Indeed, stained
fin sections from 48 to 72 hpa BMPRi-treated fish exhibited a
dramatic increase of nuclear-localized b-catenin throughout an
expanded population of Runx2+ preosteoblasts (Figures 7A–7E
and 7G–7K). The domain of axin2 expression also was expanded
proximally in BMPRi-exposed fish, further indicating that BMP
functions in proximal osteoblasts to restrain Wnt activity to the
distal-most progenitor pool (Figures 7F and 7L).
Cultured primary caudal fin osteoblasts became uniformly
pSmad1/5/8+ without the addition of exogenous BMP, suggest-
ing cell autonomous BMP production and signaling (Figures
S7R–S7U). Among BMPs reported to be expressed in the regen-
erating fin (Smith et al., 2006), we detected robust expression of
bmp2b in cultured osteoblasts by quantitative RT-PCR (qRT-
PCR) (Figure S7V). We reconstituted BMP’s negative regulation
of Wnt/b-catenin by combined addition of BMPRi and recombi-
nant Wnt3A to primary fin osteoblasts. Wnt3A induced partial
nuclear accumulation of b-catenin (Figures 7M–7S), which was
substantially enhanced by inhibiting BMP signaling using BMPRi
(Figures 7P–7S, p < 0.01). These results are congruent with our
in vivo observations that BMP signaling is active in osteoblasts
where its roles include negatively regulating Runx2+ preosteo-
blasts by countering Wnt signals.
Dkk proteins compete with Wnt ligands for binding to Fz/
Lrp5/6 receptor complexes (Mao et al., 2001). We therefore hy-
pothesized that BMPs could negatively regulate Wnt/b-catenin
signaling by activating Dkk expression. Primary fin osteoblasts
expressed dkk1a, dkk1b, dkk2, and dkk3b, among which
dkk1a, dkk1b, and dkk3b expression were reduced upon BMPRi
treatment, as was sp7 (Figure 8A, p < 0.05). We next examined
BMP-dependent expression of dkk genes in regenerating fins
from fish treated with DMSO or BMPRi from 48 to 96 hpa.
Dkk1b, dkk2, and dkk3b all were significantly downregulated in
BMPRi-treated animals (Figure 8B, p < 0.05). Consistent with
antibody staining and the in vitro results, sp7 transcript levels
were also reduced upon BMPRi treatment. Dkk2was downregu-
lated by BMPRi in vivo but not in cultured cells, possibly reflect-
ing nonosteoblast expression of dkk2 in intact fins. Unique
among Dkk proteins, Dkk3 is not thought to directly antagonize
Wnt/receptor interactions (Mao et al., 2001). Nevertheless,
dkk3b was enriched in regenerating osteoblasts, and its expres-
sion was reduced by a 24 hr BMPRi treatment from 48 to 72 hpa
(Figures S8A and S8B).
The BMP-dependent expression of dkk1b and its ability to
inhibit Wnt signaling in zebrafish (Shinya et al., 2000) and atten-
uate fin regeneration (Stoick-Cooper et al., 2007) suggested that
Dkk1b may be sufficient to inhibit the Wnt-dependent Runx2+
preosteoblast pool. We amputated fins from control and
Tg(hsp70l:dkk1b-GFP)w32 fins, subjected them to a heat shockom fish exposed to DMSO (I–L) or Wnt inhibitor (M–P, 10 mM IWP-2 from 0 to
n. Nuclei are stained blue. Scale bars represent 50 mm.
10 mM from 48 to 72 hpa) fish harvested 72 hpa. The red arrows point to twist2-
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Figure 5. Wnt Is Required forMaintenance ofRunx2+ Preosteoblasts
during Fin Regeneration
(A–D) Runx2 (A–D, red), b-catenin (A and B, green), and sp7 (C and D, green)
protein expression on sections from DMSO (A and C) and IWP-2-treated
(B and D, 10 mM from 48 to 72 hpa) fish. In (A) and (B), yellow arrows indicate
Runx2+ cells with nuclear-localized b-catenin and the red arrow points to a
Runx2+ cell lacking nuclear b-catenin. In (C) and (D), red arrows show Runx2+
cells, yellow arrows point to Runx2+/sp7+ cells, and green arrows mark sp7+
cells.
(E and F) b-catenin localization at 72 hpa in DMSO (E) and IWP-2-treated fish
(F, 10 mM at 64–72 hpa). The osteoblast-populated domain of the blastema is
bounded by a dashed white box, and the white arrows point to osteoblasts
with b-catenin expression.
(G and H) Runx2 (red) and sp7 (green) levels in DMSO (G) and IWP-2-treated
fins (H, 10 mM at 64–72 hpa) harvested 72 hpa. Red, yellow, and green arrows
indicate Runx2+, Runx2+/sp7+, and sp7+ cells, respectively. Nuclei are in blue.
Scale bars represent 50 mm.
(I) Osteoblast subtype percentile representation onmatched fin sections (n > 6
rays collected from three animals and representing >600 osteoblasts for each
treatment) harvested 72 hpa following DMSO (64–72 hpa), Wnt-C59 (100 nM,
64–72 hpa), or IWP-2 (10 mM, 64–72 hpa) exposure. Asterisks indicate signif-
icant differences relative to DMSO-treated fish (all p < 0.02, one-tailed
Student’s t tests).
(J) Percentage of Runx2+ and Runx2+/sp7+ osteoblasts in the same sections
scored in (I) that had incorporated EdU. Asterisks indicate a significant
decrease (p < 0.003, one tailed Student’s t tests).
Cregimen from 48 to 72 hpa, and examined b-catenin localization
and Runx2 expression. Dkk1b induction decreased nuclear-
localized b-catenin and produced a pronounced deficiency in
Runx2+ preosteoblasts (Figures 8C–8H), consistent with Dkk1b
being a potent BMP-dependent inhibitor of osteoblast progeni-
tor renewal.
The division of regenerating fin osteoblasts into distal Wnt
active and proximal BMP active populations suggests the
pathway’s respective ligands would be similarly distributed.
Guided by earlier studies (Poss et al., 2000; Smith et al.,
2006; Stoick-Cooper et al., 2007), we determined the cell spe-
cific expression patterns of bmp2b, wnt5a, wnt5b, and wnt10a
transcripts on 72 hpa fin sections. In situ hybridization revealed
that bmp2b mRNA was produced by differentiating proximal
osteoblasts (Figure S8C). In contrast, expression of wnt5a (Fig-
ure S8D) and wnt5b (Figure S8E) was concentrated toward the
distal end of the regenerating fin, in both blastema mesen-
chymal cells and basal epidermis. Although more weakly ex-
pressed, wnt10a was also present in distal and lateral
regions of the blastema in or adjacent to osteoblasts (Fig-
ure S8F). To conclusively identify the cellular sources of
wnt5a and bmp2b relative to osteoblast lineage cells, we per-
formed double immunostaining/in situ hybridization studies.
Wnt5a expression was expressed in mesenchymal cells occu-
pying the extreme distal blastema bordered laterally by Runx2+
preosteoblasts. Minimal wnt5a was detected in Runx2+ preos-
teoblasts or blastema cells adjacent to maturing sp7-express-
ing osteoblasts (Figures 8I–8L). Bmp2b was expressed in
maturing sp7+ osteoblasts, but not Runx2+ distal preosteo-
blasts (Figures 8M–8P). Based on their spatial separation,
Wnt5a/5b and Bmp2b are attractive candidate ligands to simul-
taneously promote the opposing activities of Wnt-dependent
preosteoblast maintenance and BMP-dependent osteoblast
differentiation, respectively.ell Reports 6, 482–498, February 13, 2014 ª2014 The Authors 491
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DISCUSSION
Bone regeneration in zebrafish fins requires regulatory mecha-
nisms to (1) generate dedifferentiated progenitors from mature
osteoblasts, (2) maintain this preosteoblast population until
regeneration is complete, and (3) spatially and temporally restrict
redifferentiation to a subset of preosteoblasts that progressively
reform lost bone. The latter two processes are opposing activ-
ities; a fine balance between progenitor expansion and terminal
differentiation must be maintained to sustain bone regeneration
over 2 or more weeks. Our studies suggest a model for bone
regeneration in the fin (Figure 8Q) whereby a Wnt-dependent
EMT of epithelial osteoblasts populates the newly formed
blastema with dedifferentiated Runx2+ preosteoblasts. Spatial
segregation of two opposing pathways, Wnt/b-catenin and
BMP, then balances growth and differentiation until regeneration
is complete. Sustained high levels of Wnt in the distal blastema
directly and continuously maintain a leading edge pool of
Runx2+ mesenchymal preosteoblasts. Conversely, as more
proximally located Runx2+ cells become physically distanced
from the distal Wnt source, they upregulate bmp2b and activate
autocrine BMP signaling. BMP promotes osteoblast differentia-
tion by inducing sp7 and dkk1b expression to feedback inhibit
Wnt activity and prevent unproductive overexpansion of the pro-
genitor pool. In agreement, dkk1b promoter elements drive gene
expression exclusively in differentiating osteoblasts near the
amputation site (Kang et al., 2013). As osteoblast maturation
ensues, sp7-expressing cells downregulate Runx2, re-epitheli-
alize by reforming adherens junctions, and progressively extend
new mineralized bone (Figure 8Q).
Specific Roles for Wnt and BMP in the Osteoblast
Lineage during Regeneration
Our examination of canonical Wnt activity shows that osteo-
blasts are a major Wnt-responsive cell type in the regenerating
fin. Rapid changes in preosteoblast subtypes and their prolifera-
tion with short-termWnt inhibitor exposure and the sufficiency of
recombinant Wnt to promote osteoblast proliferation demon-
strate canonical Wnt directly affects preosteoblasts. The
requirement for Wnt in Runx2+ preosteoblast proliferation during
fin regeneration is consistent with known functions for the Wnt/
b-catenin pathway in maintaining progenitor cells in diverse bio-
logical settings (Clevers and Nusse, 2012) and regulating boneFigure 6. BMP/Smad Signaling Promotes Osteoblast Differentiation an
(A) Runx2 (white), sp7:EGFP (green) and pSmad1/5/8 (red) levels on sections f
osteoblasts. Red arrows indicate sp7+/pSmad1/5/8+ osteoblasts. The amputatio
(B–I)Whole-mount images of regenerating fins of Tg(sp7:EGFP) fish at 8 dpa after
(B, D, F, and H) and epifluorescence images (C, E, G, and I) to visualize sp7:EG
sentative images from one of three fish in each of the control and BMPRi groups
(J–O) Antibody-stained fin sections showing Runx2 (red) and pSmad1/5/8 (green
48–72 hpa). Red arrows indicate Runx2+/pSmad cells, and the yellow arrow po
(P–S) EdU (white) incorporation in Runx2- (red) and sp7- (green) expressing cells in
at 48–72 hpa). Red arrows indicate Runx2+ cells and green arrows point to sp7+
sent 50 mm.
(T) The percentage of Runx2+ (red bars), Runx2+/sp7+ (yellow bars), and sp7+ ce
(5 mM, 48–72 hpa) zebrafish. Four rays from three BMPRi-exposed animals conta
shared with the experiment shown in Figure 5I. Error bars are one SD, and significa
p < 0.007 for a decrease in Runx2+/sp7+ cells; and p < 0.02 for a decreased sp7
Cdevelopment in mice (Day et al., 2005; Glass et al., 2005; Gong
et al., 2001; Hill et al., 2005; Hu et al., 2005; Rodda and
McMahon, 2006). Precisely how Wnt/b-catenin signaling sup-
ports the preosteoblast state requires further study, but it is likely
that Wnt/b-catenin’s effects on transcription favor the silencing
of genes required for differentiation and activation of genes
associated with ‘‘stemness’’ (Clevers and Nusse, 2012).
We also observed axin2 and TOP:GFP expression, as well as
modest nuclear b-catenin in nonosteoblast distal blastema cells,
indicating they, like preosteoblasts, are Wnt responsive. A role
for Wnt signaling outside of osteoblasts is supported by our
long-term Wnt inhibitor and Dkk1b overexpression experiments
that produce a near complete arrest of fin regeneration. There-
fore, akin to its role in preosteoblasts, canonical Wnt signaling
may maintain these distal-most blastema cells, which then act
as a signaling niche/center that orchestrates the overall fin
regeneration process. This concept is described in detail in the
accompanying paper from Wehner et al. (2014) in this issue of
Cell Reports. Wnt5a, wnt5b, and wnt10a are expressed in distal
regenerating fin tissue (Poss et al., 2000; Stoick-Cooper et al.,
2007), results we confirmed and expanded upon by demon-
strating thatwnt5a is expressed in distal blastema cells adjacent
to Runx2+ preosteoblasts. Therefore, distal blastema cells may
be a self-sustaining source of a Wnt morphogen gradient that
both directly and indirectly regulates osteoblasts and other cell
types of the regenerating fin.
Our observations show that BMP signaling likely is dedicated
to differentiating osteoblasts in regenerating fins. Antibody stain-
ing localizes pSmad1/5/8 to proximal maturing osteoblasts and
not distal Runx2+ preosteoblasts. Further, BMP receptor func-
tion is required for normal sp7 expression and bone formation,
but not to maintain distal Runx2+ cells. Intriguingly, although
distal Runx2+ cells with robust nuclear b-catenin reside near a
field of bmp expression (Smith et al., 2006), they and other distal
cells are pSmad1/5/8 negative and therefore likely refractory to
BMP signals. One possible explanation is feedback inhibition
of BMP in the distal blastema byWnt-induced BMP antagonists.
Ectopic expression of Chordin, a secreted BMP inhibitor, blocks
fin regeneration (Smith et al., 2006), although it is unknown
whether endogenous Chordin, or other BMP inhibitors, quench
BMP signals in the context of fin regeneration. We find that
cultured fin osteoblasts strongly express bmp2b and accord-
ingly become pSmad1/5/8+. Further, bmp2b expression isd sp7 Expression during Bone Regeneration
rom a Tg(sp7:EGFP) fish 4 dpa. White arrows point to Runx2+/pSmad pre-
n site is marked with a dashed yellow line.
DMSO (B–E) or BMPRi exposure (F–I, 5 mM from 0 to 8 dpa). Rotterman contrast
FP expression (green) are shown. White arrows indicate osteoblasts. Repre-
are shown at low and high magnification.
) levels in fish 72 hpa exposed to DMSO (J–L) or BMPRi (M–O, 5 mM BMPRi at
ints to a Runx2low/pSmad1/5/8+ cell. Insets show magnified boxed regions.
fin sections fromDMSO (P andQ) and BMPRi-exposed animals (R and S, 5 mM
cells. Overlay panels show Hoechst-stained nuclei in blue. Scale bars repre-
lls (green bars) in fin sections from DMSO (48–72 hpa) versus BMPRi-treated
ining a combined >400 osteoblasts were scored. The DMSO sample data are
nt p values are indicated with an asterisk (p < 0.002 for increased Runx2+ cells;
+ population, Student’s t tests).
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concentrated in differentiating sp7+ osteoblasts in vivo, as sug-
gested by an earlier study (Smith et al., 2006). Direct downstream
targets of BMP/Smad during bone regeneration could include
both sp7 and dkk genes, such as dkk1b. Our model does not
resolve if other signaling pathways required for fin ray regenera-
tion, including fibroblast growth factor (FGF) and Hedgehog
(reviewed in Gemberling et al., 2013), interface with Wnt/
b-catenin and BMPs in osteoblasts or have secondary effects
on regenerating bone.
Opposing Activities of Wnt and BMP Establish Self-
Renewing Tissues and Organs
Self-renewing tissues, including intestinal epithelium, stomach
lining, interfollicular epidermis, sebaceous glands, and hair folli-
cles of the skin, contain stem cells that produce cells whose dif-
ferentiation states are both temporally and spatially arranged
(Barker et al., 2010). The logic of how these hierarchical progen-
itor cell systems are maintained is remarkably similar to what we
describe during fin bone regeneration with Wnt/BMP mutual
antagonism being a common theme (Kandyba et al., 2013; Plikus
et al., 2008). Mathematical models predict an obligatory role for
negative feedback loops to balance stem cell renewal and differ-
entiation (Lander et al., 2009). Therefore, an equilibrium between
Wnt and BMP output may be a common logic component of reg-
ulatory networks that establish a precise balance between cell
plasticity and differentiation.
Implications for Restorative Bone Therapies
Our interpretation of bone regenration in the zebrafish fin sug-
gests that the signaling networks that control regenerative os-
teogenesis are evolutionarily conserved, relatively simple, and
largely lineage intrinsic. Human bonemay retain the competency
to robustly regenerate if inherent networks could be somehow
activated and/or augmented. Currently, recombinant BMPs are
the only biologic factors approved for use in bone repair thera-
pies; however, whereas BMPs can promote ossification, their
clinical efficacy is controversial (Garrison et al., 2010). A potential
explanation for this can be inferred from our results and those of
others that show that BMPs downregulate Wnt/b-catenin signal-
ing in bone (Minear et al., 2010a). New therapeutic approaches
can be envisioned that exploit the features of regenerative osteo-
genesis that we have uncovered. For instance, first enhancing
Wnt/b-catenin activity using small molecules or Wnt proteins
soon after injury may expand endogenous preosteoblasts, an
idea supported by enhanced healing of damaged bone in mice
treated with recombinant Wnts (Minear et al., 2010b). Then, laterFigure 7. BMP Negatively Regulates Wnt/b-Catenin Signaling
(A–L) Immunostaining (A–E and G–K) with Runx2 (red) and b-catenin (green) antibo
and BMPRi-treated fish (G–L, 5 mMat 48–72 hpa). Yellow arrows highlight Runx2+
membrane-localized b-catenin. Hoechst-stained nuclei are in blue. For (F) and (L),
red arrows point to proximal axin2+ osteoblasts. Scale bars represent 50 mm (A–
(M–R) Runx2 expression (red) and b-catenin localization (green) in antibody-staine
BMPRi + Wnt3a (P–R, 300 nM and 40 ng/ml, respectively) for 24 hr beginning
localization, and yellow arrows indicate Runx2+ cells displaying nuclear b-cateni
(S) Plots showing nuclear-localized b-catenin versus total cell b-catenin in Runx2+
Wnt3 (40 ng/ml), or BMPRi + Wnt3a (300 nM and 40 ng/ml, respectively) expo
displayed significantly increased nuclear b-catenin relative to the Wnt3A-alone-t
(p > 0.01, indicated by an asterisk).
Cstages of bone healing may benefit from BMP treatment to
enhance osteoblast redifferentiation and mineralization. More
broadly, our observations encourage approaches aimed at
coaxing human cells to mimic those of animals, like zebrafish,
that have remarkably robust regenerative abilities.
EXPERIMENTAL PROCEDURES
Zebrafish
Wild-type AB, Tg(sp7:EGFP)b1212 (DeLaurier et al., 2010), Tg(hsp70l:dkk1b-
GFP)w32 (Stoick-Cooper et al., 2007), Tg(dusp6:Cre-ERT2,myl7:ECFP)
b1230 (Stewart and Stankunas, 2012), Tg(TOP:GFP)w25 (Dorsky et al.,
2002), and Tg(Xla.Eef1a1-actb2:LOXP-LOX5171-FRT-F3-EGFP,mCherry)
vu295a (Boniface et al., 2009) lines were maintained according to University
of Oregon institutional guidelines. Regeneration studies were performed at
28C –29C as described previously (Stewart and Stankunas, 2012).
Immunostaining
Sections were rehydrated and antigen retrieval was performed for 10 min in a
pressure cooker in retrieval buffer (1 mM EDTA [pH 8], 0.1% Tween 20). Anti-
bodies were diluted in PBST containing 10% nonfat dry milk and applied to
slides overnight at 4C, followed by staining with Alexa-conjugated secondary
antibodies (Invitrogen) and Hoechst nuclear staining. Antibody staining details
are provided in the Supplemental Experimental Procedures.
Drug Treatments
Wnt pathway inhibitor IWP-2 and the BMPR inhibitor, LDN193189, referred to
in the text and figures as BMPRi, were purchased from StemRD;Wnt-C59 was
from Biovision; all were dissolved in DMSO. At the indicated times after fin
amputation, IWP-2, Wnt-C59, BMPRi, or DMSO was added to fish water
(one animal per 200 ml of water) at 10 mM, 100 nM, or 5 mM, respectively.
For each drug treatment (n = 3), cohorts of three or four animals were used,
each was analyzed at the completion of the study, and images shown are
representative examples of each cohort.
In Situ Hybridization
For combination fluorescent in situ hybridization immunostaining, sections on
slides were sequentially antigen retrieval treated, hybridized with DIG-labeled
probes, stained with a-DIG peroxidase-conjugated antibody (Roche), devel-
oped using the TSA system (PerkinElmer), and finally immunostained. Protocol
details and probe synthesis are described in the Supplemental Experimental
Procedures.
Heat Shock Studies, EdU Labeling, Osteoblast Cell Culture,
Quantitative RT-PCR, Mosaic Analysis, TUNEL Staining, and
Histology
These methods are presented in the Supplemental Experimental Procedures.
Statistical Analysis
Statistically significant differences between osteoblast subtypes were deter-
mined by scoring their fractional representation on comparable immuno-
stained sections (for Figures 1 and 5, >600 osteoblasts from more than sixdies and axin2 in situ hybridization (F and L) on sectioned fins fromDMSO (A–F)
cells with nuclear-localized b-catenin, and red arrows point to osteoblasts with
axin2 expression (blue) in distal osteoblasts is indicated by black arrows. In (L),
C and G–I) and 25 mm (D, E, J, and K).
d primary zebrafish fin osteoblasts grown in media containing DMSO (M–O) or
at 4 days postisolation. Green arrows point to cells with nuclear b-catenin
n.
cells in individual, randomly selected cultured fin osteoblasts following DMSO,
sure. A line marks the mean of each group. The Wnt3a + BMPRi population
reated group as determined by one-way ANOVA and a post hoc Tukey’s test
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Figure 8. Spatially Distributed Gene Expression Combined with Negative Feedback Maintains Regenerative Osteogenesis
(A) Quantitative RT-PCR analysis of sp7 and dkk genes in primary fin osteoblasts after 24 hr of 300 nM BMPRi (red bars and error bars) relative to control
DMSO-treated cells (variation shown with black error bars). For each primer pair, the normalized average fold change in transcript levels upon BMPRi treatment
is plotted on a log2 scale with DMSO samples averaged to log20 = 1. Each group includes three independent cultures. Error bars are one SD. Statistically
significant differences are indicated with an asterisk (p < 0.05, two-tailed Student’s t tests). A representative example of three independent experiments is
shown.
(B) Relative gene expression of osteogenic factors and dkk genes at 96 hpa following DMSO (black error bars) or BMPRi exposure (red bars, 5 mM from 48 to
96 hpa). Mean normalized levels of the indicated transcripts from four fins per treatment group are shown on a log2 scale. Error bars represent one SD, and
asterisks mark differentially expressed genes (p < 0.05, two-tailed Student’s t tests).
(C–H) Antibody staining for Runx2 (red) and b-catenin (green) on sectioned fins from control (C–E, two heat treatments between 48 and 72 hpa) and
Tg(hsp70l:dkk1b-GFP) fish (F–H, two heat treatments between 48 and 72 hpa) harvested 72 hpa. The yellow arrow indicates Runx2+ cells with nuclear b-catenin.
(I–L) Immunostaining of a 72 hpa fin cryosection with Runx2 (I, white) and sp7 (J, green) antibodies and simultaneous wnt5a mRNA in situ hybridization (K, red),
overlaid in (L). The red arrow shows wnt5a expression in distal mesenchymal cells.
(M–P) A fin cryosection from a 72 hpa Tg(sp7:EGFP) fish showing antibody staining for Runx2 (M, white) and EGFP (N, green) and bmp2b mRNA in situ
hybridization (O, red), overlaid in (P). The white arrow points to Runx2+/bmp2b cells, and yellow arrows indicate overlapping expression of sp7:EGFP and
bmp2b. Hoechst-stained nuclei are in blue in overlay panels. Scale bars represent 50 mm.
(Q) A signaling network model for osteogenesis during fin regeneration. Wnt acts distally to maintain a pool of Runx2+ osteoblast progenitor cells, whereas
Bmp2b-initiated signaling in progenitor-derived cells both promotes sp7-associated differentiation and constrains Wnt activity by inducing Dkk1b.rays compiled from at least three fish; for Figure 6, >400 osteoblasts frommore
than four rays collected from at least three animals). One-tailed Student’s
t tests compared the means of each population’s percentage of total osteo-
blasts across individual rays. Fisher’s exact tests were used to determine
significant differences in the proportion of EdU+ cells between osteoblast sub-
types, combining osteoblasts scored in 12 rays from at least four fish (>1,100
cells total). To assess changes in EdU incorporation between drug-treated
fish, comparable stained sections were scored for the fraction of EdU incorpo-
rating cells of each osteoblast subtype. Student’s t tests assessed differences
between drug-treated groups using the means of each subtype’s percentage
of EdU+ incorporating cells across individual rays. For nuclear b-catenin quan-
titation in cultured osteoblasts, one-way ANOVA and post hoc Tukey’s tests496 Cell Reports 6, 482–498, February 13, 2014 ª2014 The Authorswere used to determine significant differences in the ratio of nuclear to total
b-catenin in individual cells across and between treatments. To determine
differentially expressed gene in qRT-PCR studies, two-tailed Student’s t tests
used raw DCts from three or four independent control and experimental
samples.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and eight figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2014.01.010.
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